Even though IGFBP6 and IGFBP7 overexpression were not significantly correlated to steatosis grade or NAS by Stanley et al. their potential function in the pathological progression of NAFLD is still under investigation [30]. Here, IGFBP6 is linked to metabolic dysfunction-associated steatotic liver disease.